IMAC Holdings Inc BACK:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/17/24 EDT
3.22quote price arrow down-0.16 (-4.73%)
Volume
261
Close
3.38quote price arrow up+0.24 (+7.64%)
Volume
42,910
52 week range
1.22 - 7.75
Loading...
  • Open3.11
  • Day High3.55
  • Day Low3.10
  • Prev Close3.14
  • 52 Week High7.75
  • 52 Week High Date04/25/24
  • 52 Week Low1.22
  • 52 Week Low Date03/15/24

Key Stats

  • Market Cap3.881M
  • Shares Out1.15M
  • 10 Day Average Volume0.07M
  • Dividend-
  • Dividend Yield-
  • Beta0.24
  • YTD % Change52.94

KEY STATS

  • Open3.11
  • Day High3.55
  • Day Low3.10
  • Prev Close3.14
  • 52 Week High7.75
  • 52 Week High Date04/25/24
  • 52 Week Low1.22
  • 52 Week Low Date03/15/24
  • Market Cap3.881M
  • Shares Out1.15M
  • 10 Day Average Volume0.07M
  • Dividend-
  • Dividend Yield-
  • Beta0.24
  • YTD % Change52.94

RATIOS/PROFITABILITY

  • EPS (TTM)-5.82
  • P/E (TTM)-0.58
  • Fwd P/E (NTM)-0.98
  • EBITDA (TTM)-2.815M
  • ROE (TTM)-332.19%
  • Revenue (TTM)-
  • Gross Margin (TTM)88.69%
  • Net Margin (TTM)-176.21%
  • Debt To Equity (MRQ)5.69%

EVENTS

  • Earnings Date08/06/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On IMAC Holdings Inc

 

Profile

MORE
IMAC Holdings, Inc. is a clinical research and commercialization company. The Company is focused on innovative medical advancements and care in the oncology, neurological, and orthopedic medical specialties. The Company is focused on providing natural, non-opioid solutions to pain as consumers demand conservative treatments for an aging population. Its Investigational New Drug division conducted a clinical trial for its investigational compound utilizing umbilical...
Jeffrey Ervin
Chairman of the Board, Chief Executive Officer, Co-Founder
Sheri Gardzina CPA
Chief Financial Officer
Address
1605 Westgate Cir
Brentwood, TN
37027
United States